About one in eight adults -- or roughly 12% -- said they are currently taking a GLP-1 drug to help them lose weight or treat a chronic condition, which is an increase from 18 months ago, according to recent KFF Health Tracking Poll
Competing interests ML, FL, CR-D, AL, and RP are employees of, and are shareholders in, Sanofi
This standardization makes it easier to switch between vial sizes without changing your unit measurements, which is why experienced users often request this concentration specifically
They're actually strong enough to grow out now
Key Takeaways Microdosing could theoretically reduce peak-to-trough ratios by 28-38%, potentially minimizing side effects Successful precedents exist with insulin and growth hormone therapies using similar principles Mathematical models suggest maintained efficacy (~75-100%) with appropriate dose adjustments No clinical trials have validated microdosing for GLP-1 agonists - all evidence is theoretical or anecdotal 55% of microdosers make decisions without physician consultation, raising safety concerns What Is Retatrutide Microdosing